Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Pyrilutamide did not show effectiveness in regrowing hair compared to a placebo, but it may still help maintain existing hair by preventing DHT from causing follicle miniaturization. Some users believe it could be beneficial when used with other treatments like minoxidil, finasteride, and dutasteride.

Adding RU58841 to Dutasteride treatment helped reduce hair shedding significantly for several users. Some reported no change with RU58841, while others experienced a dramatic decrease in shedding and increased hair density.

The post discusses the difference in effects of Minoxidil (Min) on scalp and facial hair. The user questions why Min-induced hair growth on the scalp is temporary, while facial hair growth seems permanent, even after stopping Min. They propose theories, including different Min mechanisms on body and facial hair, the role of DHT, and the possibility of not achieving fully terminal hair. The responses include personal experiences and theories about Min's effects on hair growth.

The conversation discusses doubts about the effectiveness of topical finasteride for hair loss, suggesting that DHT could be produced elsewhere in the body and affect the scalp. It proposes that androgen receptor antagonists like spironolactone and clascoterone might be more effective as they could prevent this potential bypass mechanism.

The conversation discusses the potential benefits of sublingual minoxidil for hair loss treatment. It suggests that sublingual minoxidil, which bypasses the liver, may have fewer side effects, greater bioavailability, and could be more effective than oral minoxidil.

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

Isotretinoin may cause hair loss by increasing DHT through a precursor androgen, DHEAS. Treatments like topical antiandrogens (RU58841, pyrilutamide) and drugs increasing PPAR-y expression (pioglitazone) might prevent this hair loss.

RU58841 combined with finasteride or dutasteride is more effective than RU58841 alone for hair loss. Users suggest combining these with minoxidil and microneedling for better results.

The user experienced success in reducing hair thinning using a combination of rosemary oil, black seed oil, and microneedling, avoiding finasteride and minoxidil due to side effects. They later stopped using black seed oil due to concerns about increased testosterone.

Topical finasteride is discussed as an alternative to oral finasteride, with some users experiencing fewer side effects and positive results. RU58841 and minoxidil are also mentioned as effective treatments for hair loss.

Potential success with the hair loss treatment Pyrilutamide, and possible group buying opportunities for it along with other treatments such as Finasteride and Minoxidil.

Mixing spironolactone with minoxidil for hair loss is questioned, but concerns are raised about spironolactone's side effects, especially for men. RU58841 is suggested as a better alternative for topical use.

The user has been using finasteride and minoxidil for hair loss but experienced worsening temple recession. They suspect they might be more sensitive to testosterone and are considering trying RU58841 or CB 03 01 as additional treatments.

Using creatine to balance side effects of topical finasteride is debated, with concerns it may reduce finasteride's effectiveness. Some users consider alternatives like cordyceps mushroom extract, while others question creatine's impact on DHT levels.

A 22-year-old is considering using finasteride daily with 3-5g of creatine to manage hair loss and reduce finasteride side effects. Users discuss the potential impact of creatine on DHT levels and its interaction with finasteride.

An 18-year-old is considering using RU58841 for aggressive hair loss and is also thinking about taking creatine. Users suggest avoiding creatine due to its potential to increase DHT and recommend using topical finasteride instead.

The user started finasteride at 21.5 years old and saw significant improvement in hair volume and maintenance of the hairline, though some recession continued. They are optimistic about future hair loss treatments like CRISPR and are not currently using additional treatments like minoxidil or derma-rolling.

The user experienced side effects from daily 1 mg Finasteride and switched to 0.5 mg every other day, supplemented with creatine, tongkat ali, tribulus terrestris, vitamin D3, bromantane, l-tyrosine, and caffeine. They also use weekly 1.5 mm microneedling and daily 50 mg RU58841, except on microneedling days, to manage hair loss.

Breezula protects hair follicles from both testosterone and DHT, unlike finasteride, which only protects against DHT. This could potentially lead to significant hair regrowth, similar to results seen in transgender individuals using hormone blockers.

RepliCel's potential hair loss treatment may cost around $1000 and aims to protect hair follicles from DHT, possibly reversing some miniaturization. It is not considered a cure and may be most effective in early hair loss stages, with its main advantage over finasteride being the lack of sexual side effects.

A 21-year-old is experiencing worsening hair loss and has tried Rogaine and Propecia, considering generics due to cost. They are advised to consider finasteride, hair transplant surgery, or PRP therapy, while also expressing concerns about potential side effects and waiting for a dermatologist appointment.

Hair loss may be influenced by mechanical tension and inflammation, with the hi-c5 protein amplifying androgen effects, leading to follicle miniaturization. Treatments like finasteride, minoxidil, and scalp massages are suggested to manage hair loss.

Microneedling may stimulate hair regrowth independently and could potentially enhance the effects of oral minoxidil, though evidence is limited. Some users report positive results with microneedling, but concerns about scarring and the need for proper technique are noted.

RU58841 is considered ineffective as a standalone treatment for hair loss, with users often combining it with finasteride and minoxidil for potential benefits. Many users report mixed results and concerns about side effects, leading to skepticism about its efficacy.

Finasteride maintains its efficacy over time, slowing hair loss but not completely stopping it. Long-term users often experience stability, though natural aging may cause gradual decline; additional treatments like minoxidil, RU58841, and others may be needed for aggressive hair loss.

A user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, but experienced worsening hair loss and thinning. Suggestions included returning to finasteride, adding finasteride to the current regimen, or considering other factors like genetics or additional causes of hair loss.

A user shared their experience with hair regrowth using supplements like NAC and DIM, and briefly using minoxidil with microneedling. They reported some improvement in hair density, but the community questioned the effectiveness compared to traditional treatments like finasteride.

A 31-year-old man has been using Dutasteride since 2022, alongside topical Minoxidil, with positive results and no issues. His new healthcare provider expressed concerns about long-term Dutasteride use and suggested alternatives like oral Minoxidil and Spironolactone, but the patient is hesitant to change a successful routine.

Gut microbiome imbalances can cause scalp inflammation and affect hair follicles, potentially leading to hair loss. Treatments include finasteride, peptides like BPC-157, TB-500, KPV, and lifestyle changes such as diet and exercise.

The user experienced significant hair regrowth using a combination of minoxidil, alfatradiol, pyrilutamide, and nizoral, despite previous intolerance to finasteride. They emphasize the importance of consistency in treatment and are optimistic about the results, noting no side effects so far.